Actionable biomarker co-expression in advanced ovarian cancer: folate receptor alpha expression and related markers

By afschroeder • August 26, 2026

Shachar EK, Silverstein J, Gornbein J, Salani R, Karlan BY, Chase DM. Actionable biomarker co-expression in advanced ovarian cancer: folate receptor alpha expression and related markers. Int J Gynecol Cancer. 2026 Aug 6:104893. doi: 10.1016/j.ijgc.2026.104893. Epub ahead of print. PMID: 42642279.

Tags: biomarkers, Co-Expression, DOM STAT, estrogen receptor, Folate receptor alpha, General Internal Medicine, Hematology/Oncology, ovarian cancer, Publications

Profound Hypothyroidism as a Reversible Cause of Severe Low-Density Lipoprotein Cholesterol (LDL-C) Elevation: A Case Report

Mataraarachchi NE, Bhat S. Profound Hypothyroidism as a Reversible Cause of Severe Low-Density Lipoprotein Cholesterol (LDL-C) Elevation: A Case Report. Cureus. 2026 Jul 25;18(7):e113365. doi:[...]

Mitochondrial NCLX Couples Glucagon- and PDE2A-Dependent Signals to Regulate Hepatic Lipid Metabolism

Assali EA, Taha M, Salhab A, Amer J, Krishnan KC, Kostic M, Veliova M, Brownstein AJ, Shirihai OS, Safadi R, Sekler I. Mitochondrial NCLX Couples[...]

Feasibility of Using Clinicians to Code the Actionability of Narrative Comments About Patient Experience for Quality Improvement

Quigley DD, Predmore Z, Panayotou MS, Elliott MN, Hays RD. Feasibility of Using Clinicians to Code the Actionability of Narrative Comments About Patient Experience for[...]